William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 5,934 shares at $31.84 ($189K) on 2024-08-21, disclosed to the SEC on 2024-08-23.
Open-market sale of $189k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.84 | 2,907 | $93K | 49.0% |
| 2 | $31.84 | 2,907 | $93K | 49.0% |
| 3 | $32.32 | 120 | $4K | 2.1% |
| Total | $31.85 avg | 5,934 | $189K | 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $160K | — | Filing → |